Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal Bhatnagar

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
Journal of the National Cancer Institute|August 29, 2020
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer TrialsPaul G Kluetz, Bellinda L King-Kallimanis, Daniel Suzman, et al.
Cancer|October 11, 2021
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancerMeena N Murugappan, Bellinda L King-Kallimanis, Christina Mangir, et al.
Cancer|April 7, 2022
Reply to "Another look at floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning subscale and possible solutions"Meena N Murugappan, Bellinda L King-Kallimanis, Christina Mangir, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast CancerTing-Yu Chen, Bellinda L King-Kallimanis, Lyna Merzoug, et al.
Blood|May 4, 2023
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trialsBindu Kanapuru, Laura L Fernandes, Andrea Baines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell LymphomasMaryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2021
Perspectives on Drug Development in Multiple Myeloma-Looking Forward to 2025Peter M Voorhees, Andrzej J Jakubowiak, Shaji K Kumar, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Leukemia Research|May 19, 2015
Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemiaAshkan Emadi, Mariola Sadowska, Brandon Carter-Cooper, et al.
Journal of the National Cancer Institute|August 29, 2020
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer TrialsPaul G Kluetz, Bellinda L King-Kallimanis, Daniel Suzman, et al.
Cancer|October 11, 2021
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancerMeena N Murugappan, Bellinda L King-Kallimanis, Christina Mangir, et al.
Cancer|April 7, 2022
Reply to "Another look at floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning subscale and possible solutions"Meena N Murugappan, Bellinda L King-Kallimanis, Christina Mangir, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast CancerTing-Yu Chen, Bellinda L King-Kallimanis, Lyna Merzoug, et al.
Blood|May 4, 2023
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trialsBindu Kanapuru, Laura L Fernandes, Andrea Baines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell LymphomasMaryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2021
Perspectives on Drug Development in Multiple Myeloma-Looking Forward to 2025Peter M Voorhees, Andrzej J Jakubowiak, Shaji K Kumar, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Pageof 8